Asset management firm Capital Group, which has an emerging markets-focused private equity practice, has been investing selectively in India for years. However, most of these investments have yielded modest annualised returns. Now, the investment group is finally looking to strike a multi-bagger as its portfolio company Mankind Pharma goes public. […]
This post is only available to members.